25Nov/13

Boston Scientific Gets FDA Approval For Promus Premier Everolimus-EPCCS … – RTT News

Boston Scientific Gets FDA Approval For Promus Premier Everolimus-EPCCS
RTT News
Boston Scientific Corp. (BSX: Quote) said Monday that it has received U.S. Food and Drug Administration or FDA approval for the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System, the company’s next-generation durable 
Boston Scientific Receives FDA Approval For Promus Premier(TM) Everolimus Wall Street Journal
Boston Scientific Receives FDA Approval For Promus Premier Everolimus Benzinga
FDA approves next-generation EESHealio
Forbes –MedCity News –Worcester Business Journal
all 10 news articles »
25Nov/13

Boston Scientific Corporation : Boston Scientific Receives FDA Approval For … – 4-traders (press release)

Boston Scientific Corporation : Boston Scientific Receives FDA Approval For
4-traders (press release)
25, 2013/PRNewswire/ — Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the Promus PREMIER™ Everolimus-Eluting 

25Nov/13

Boston Scientific Gets FDA Approval For Promus Premier Everolimus-EPCCS … – NASDAQ

Boston Scientific Gets FDA Approval For Promus Premier Everolimus-EPCCS
NASDAQ
(RTTNews.com) – Boston Scientific Corp. ( BSX ) said Monday that it has received U.S. Food and Drug Administration or FDA approval for the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System, the company’s next-generation 
Boston Scientific Receives FDA Approval For Promus Premier(TM) Everolimus Wall Street Journal
FDA approves next-generation EESHealio
BSX scores FDA device approval for drug-eluting stent for coronary artery MedCity News
Worcester Business Journal
all 10 news articles »
25Nov/13

Cardiac Biomarker ST2 Proves Valuable In Helping Risk Assess Heart Failure … – PharmiWeb.com (press release)

Cardiac Biomarker ST2 Proves Valuable In Helping Risk Assess Heart Failure
PharmiWeb.com (press release)
Given that over 80% of heart failure patients are 65 years of age or older1 it’s no wonder then that according to the American Heart Association the number of Americans with heart failure is expected to jump from just over 5 million today to 8 million

and more »

25Nov/13

Creating synthetic antibodies – R & D Magazine


R & D Magazine

Creating synthetic antibodies
R & D Magazine
To create these “synthetic antibodies,” the researchers used carbon nanotubes—hollow, nanometer-thick cylinders made of carbon that naturally fluoresce when exposed to laser light. In the past, researchers have exploited this phenomenon to create
Team Creates ‘Synthetic AntibodiesBioscience Technology
Synthetic antibodies work in new sensortce today

all 8 news articles »